| Serial Number | 90872641 |
| Word Mark | ITURBEV |
| Filing Date | Monday, August 9, 2021 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Tuesday, October 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 21, 2023 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 1, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Thursday, August 12, 2021 | NEW APPLICATION ENTERED |
| Friday, October 1, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 19, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, April 26, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, April 26, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 26, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 9, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, November 9, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, November 9, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, November 14, 2022 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, November 14, 2022 | PETITION TO REVIVE-GRANTED |
| Monday, November 14, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 15, 2022 | NOTICE OF REVIVAL - E-MAILED |
| Wednesday, January 11, 2023 | ASSIGNED TO LIE |
| Wednesday, January 11, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 11, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 21, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 18, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, October 5, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 14, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, March 14, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 14, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, October 3, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 3, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, October 3, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, March 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 15, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 15, 2024 | SOU EXTENSION 3 FILED |
| Tuesday, October 15, 2024 | SOU EXTENSION 3 GRANTED |